Essential Mediscience Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 68.39%
About Essential Mediscience
Essential Mediscience Private Limited (EMPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 December 2011 and has a history of 13 years and one month. Its registered office is in Dharwad, Karnataka, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Suchita Danolli and Sushant Danolli serve as directors at the Company.
Company Details
-
Location
Dharwad, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24297KA2011PTC061902
-
Company No.
061902
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Dec 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Essential Mediscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suchita Danolli
|
Director | 29-Dec-2011 | Current |
|
Sushant Danolli
|
Director | 28-Feb-2016 | Current |
Financial Performance of Essential Mediscience.
Essential Mediscience Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Essential Mediscience?
In 2017, Essential Mediscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Purogen Clean Air Systems Private LimitedSuchita Danolli is a mutual person
-
Suvenchy Estates And Boards Private Limited
Suchita Danolli and Sushant Danolli are mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Shri Arihant Credit Souhard Sahakari Ltd : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2014 | Shri Arihant Credit Souhard Sahakari Ltd | ₹1.00 Cr | Open |
How Many Employees Work at Essential Mediscience?
Unlock and access historical data on people associated with Essential Mediscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Essential Mediscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Essential Mediscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
